Company Cotinga Pharmaceuticals Inc. Toronto S.E.
Equities
COT.H
CA22164W1059
Biotechnology & Medical Research
Business Summary
Number of employees: 6
Managers
Managers | Title | Age | Since |
---|---|---|---|
Alison D. Silva
PSD | President | 46 | 01/15/01 |
Debi Sanderson
COO | Chief Operating Officer | - | - |
Chief Tech/Sci/R&D Officer | 61 | 12/17/12 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 01/18/01 | |
John C. Drake
CHM | Chairman | - | 20/07/20 |
Alison D. Silva
PSD | President | 46 | 01/15/01 |
David Sanderson
BRD | Director/Board Member | - | 05/13/05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 21,986,415 | 15,211,245 ( 69.18 %) | 0 | 69.18 % |
Company contact information
Cotinga Pharmaceuticals, Inc.
127 Main Street
02129, Boston
+
![address Cotinga Pharmaceuticals Inc.(COT.H)](https://cdn.zonebourse.com/static/address/40177867.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+15.38% | 12TCr | |
+17.62% | 11TCr | |
+17.61% | 2.62TCr | |
-23.38% | 1.9TCr | |
-19.51% | 1.57TCr | |
-18.86% | 1.52TCr | |
-47.37% | 1.47TCr | |
+58.91% | 1.46TCr | |
+5.09% | 1.38TCr |